Previous close | 2,458.05 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 0 |
Market cap | 273.07B |
Beta (5Y monthly) | 0.87 |
PE ratio (TTM) | 20.49 |
EPS (TTM) | 119.95 |
Earnings date | 24 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 08 July 2024 |
1y target est | N/A |
Quest Diagnostics (NYSE:DGX) has had a great run on the share market with its stock up by a significant 13% over the...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors has elected Robert (Rob) B. Carter, a seasoned technology executive, to serve as a director. Including Mr. Carter, the company's Board has 10 members.
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on July 22, 2024 to shareholders of record of Quest Diagnostics common stock on July 8, 2024.